The most popular keywords from 2022 to 2024 were “tumor microenvironment,” “gastric cancer,” “immune checkpoint inhibitors,” “lung cancer,” and “reactive oxygen species.” The burst of tumor microenvironment (TME) and immune checkpoint inhibitors suggests that albumin NP-based tumor immunotherapy is a current hotspot. This evidence concerns the gene ALB and lung cancer.